Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval

Go back to Sunshine Biopharma Enters the $2.8 Billion Global Dienogest Market with Canadian Regulatory Approval
Sunshine Biopharma, Inc. (NASDAQ: SBFM) Delayed: 1.14 +0.03 (2.70%)
Previous Close $1.11    52 Week High $0.04 
Open $1.14    52 Week Low $0.00 
Day High $1.14    P/E N/A 
Day Low $1.11    EPS $0.00 
Volume 82,958